1 Name of instrument
This instrument is the Radiocommunications (Low Interference Potential Devices) Class Licence Variation 2018 (No. 1).
2 Commencement
This instrument commences on the day after it is registered on the Federal Register of Legislation.
Note All legislative instruments must be registered on the Federal Register of Legislation Instruments required to be maintained under the Legislation Act 2003.
3 Authority
This instrument is made under section 132 of the Radiocommunications Act 1992.
4 Variation of Radiocommunications (Low Interference Potential Devices) Class Licence 2015
Schedule 1 varies the Radiocommunications (Low Interference Potential Devices) Class Licence 2015 [F2015L01438].
Schedule 1 Variations
(section 4)
[1] Schedule 1, after item 23
insert
| 23A | All transmitters | 122000-122250 | See limitations | (a) The maximum radiated power spectral density must not exceed 10 dBm per 250 MHz (b) The maximum radiated power spectral density must not exceed ‑48 dBm per MHz for elevations above 30 degrees. |
[2] Schedule 1, item 33, Column 4 – Limitations
omit sub-paragraph (b)(ii) and susbtitute
FCC Rules Title 47 Part 95 Sections 2573 and 2579
[3] Schedule 1, after item 34
insert
| 34A | Medical endoscopy capsule transmitters (see Note 2 and Note 3) | 430-440 | See limitations | (a) The maximum effective radiated power spectral density must not exceed ‑50 dBm per 100 kHz. (b) The total effective radiated power must not exceed ‑40 dBm within a 10 MHz measurement bandwidth (c) Both limits are intended for measurement outside the patient’s body |
[4] Schedule 1, after item 35
insert
| 35A | Medical body area network transmitters (see Note 2) | 2483.5-2500 | See limitations | The transmitter must comply with ETSI Standard EN 303 203 |
| 35B | Low power active medical implant (see Note 2) | 2483.5-2500 | See limitations | The transmitter must comply with ETSI Standard EN 301 559 |
[5] Schedule 1, item 65, Column 1
omit ‘used indoors’
[6] Schedule 1, item 65, Column 4 – Limitations
omit paragraphs (a) to (d) and substitute
The transmitter must comply with FCC Rules Title 47 Part 15 Section 255.
[7] Schedule 1, Note 2
substitute
Note 2 The systems and associated medical implant communications systems transmitters mentioned in items 33, 34, 34A, 35A and 35B are devices that require marketing approval from the Therapeutic Goods Administration.
[8] Schedule 1, immediately following Note 2
insert
Note 3 A transmitter that complies with ETSI Standard EN 303 520 will meet the requirement not to exceed the Limitations (Column 4) specified at item 34A.
[9] Schedule 2, after item 5
insert
| 5A | 35A | EN 303 203 | Electromagnetic compatibility and Radio spectrum Matters (ERM); Short Range Devices (SRD); Medical Body Area Network Systems (MBANSs) operating in the 2483.5 MHz to 2500 MHz range; | ETSI |
| 5B | 35B | EN 301 559 | Electromagnetic compatibility and Radio spectrum Matters (ERM); Short Range Devices (SRD); Low Power Active Medical Implants (LP-AMI) operating in the 2483.5 MHz to 2500 MHz range; | ETSI |
[10] Schedule 2, item 16
omit the item and substitute
| 16 | 33 | Code of Federal Regulation Title 47 §95 section 2573 | Part 95, Section 2573 MedRadio authorized bandwidth | FCC |
[11] Schedule 2, item 17
omit the item and substitute
| 17 | 33 | Code of Federal Regulation Title 47 §95 Section 2579 | Part 95, Section 2579 MedRadio unwanted emissions limits | FCC |
[12] Schedule 2, after item 17
insert
| 18 | 65 | Code of Federal Regulation Title 47 §15.255 | Part 15, Section 255 Operation within the band 57-71 GHz | FCC |